Showing results (1-10 of 344) with videos related to
Sort By:
Pageof 35
Clinical Pharmacokinetics|October 19, 2016
Clinical Determinants of Target Non-Attainment of Linezolid in Plasma and Interstitial Space Fluid: A Pooled Population Pharmacokinetic Analysis with Focus on Critically Ill PatientsIris K Minichmayr, André Schaeftlein, Joseph L Kuti, et al.Clinical Pharmacokinetics|November 26, 2023
Impact of Key Components of Intensified Ceftaroline Dosing on Pharmacokinetic/Pharmacodynamic Target AttainmentIris K Minichmayr, Sebastian G Wicha, Peter Matzneller, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 20, 2026
Continuous versus intermittent infusion of high-dose meropenem in critically ill patients: an observational cohort studyFelix Bergmann, Marlene Prager, Katarina Kumpf, et al.International Journal of Antimicrobial Agents|March 20, 2024
Integrative model-based comparison of target site-specific antimicrobial effects: A case study with ceftaroline and lefamulinWisse van Os, Anh Duc Pham, Sabine Eberl, et al.The Journal of Antimicrobial Chemotherapy|October 7, 2024
Concentrations of ceftazidime and avibactam in bile fluid-a prospective phase IIb studyAndrea Witowski, Lars Palmowski, Iris K Minichmayr, et al.Paediatric Drugs|April 8, 2024
Distribution of Bevacizumab into the Cerebrospinal Fluid of Children and Adolescents with Recurrent Brain TumorsIris K Minichmayr, Ursula Knaack, Johannes Gojo, et al.Journal of Clinical Pharmacology|March 29, 2014
Target site pharmacokinetics of linezolid after single and multiple doses in diabetic patients with soft tissue infectionRoza Badr Eslam, Angela Burian, Greisa Vila, et al.International Journal of Antimicrobial Agents|June 8, 2024
Impact of continuous-infusion meropenem degradation and infusion bag changes on bacterial killing of Pseudomonas aeruginosa based on model-informed translationIris K Minichmayr, Lena E FribergEuropean Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 20, 2013
Population pharmacokinetics meets microdialysis: benefits, pitfalls and necessities of new analysis approaches for human microdialysis dataAndré Schaeftlein, Iris K Minichmayr, Charlotte KloftPharmaceutical Research|March 18, 2021
Pharmacometrics-Based Considerations for the Design of a Pharmacogenomic Clinical Trial Assessing Irinotecan SafetyIris K Minichmayr, Mats O Karlsson, Siv JönssonPageof 35